Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
Christiana M. Neophytou, Panagiotis Boutsikos, Panagiotis Papageorgis
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Metastatic and triple-negative breast cancer: challenges and treatment options
Sumayah Al-Mahmood, Justin Sapiezynski, Olga B. Garbuzenko, et al.
Drug Delivery and Translational Research (2018) Vol. 8, Iss. 5, pp. 1483-1507
Open Access | Times Cited: 452
Recent therapeutic trends and promising targets in triple negative breast cancer
Soo‐Yeon Hwang, Seojeong Park, Youngjoo Kwon
Pharmacology & Therapeutics (2019) Vol. 199, pp. 30-57
Open Access | Times Cited: 204
Challenges and perspectives in the treatment of diabetes associated breast cancer
Samson Mathews Samuel, Elizabeth Varghese, Sharon Varghese, et al.
Cancer Treatment Reviews (2018) Vol. 70, pp. 98-111
Open Access | Times Cited: 100
The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
Elizabeth Varghese, Samson Mathews Samuel, Mariam Abotaleb, et al.
Cancers (2018) Vol. 10, Iss. 10, pp. 346-346
Open Access | Times Cited: 95
The long noncoding RNA sONE represses triple‐negative breast cancer aggressiveness through inducing the expression of miR‐34a, miR‐15a, miR‐16, and let‐7a
R.A. Youness, Hafez M. Hafez, Emad Khallaf, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 11, pp. 20286-20297
Closed Access | Times Cited: 87
A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity
Rebekah Watkins-Schulz, Pamela Tiet, Matthew D. Gallovic, et al.
Biomaterials (2019) Vol. 205, pp. 94-105
Open Access | Times Cited: 82
RETRACTED ARTICLE: Intracellular citrate accumulation by oxidized ATM-mediated metabolism reprogramming via PFKP and CS enhances hypoxic breast cancer cell invasion and metastasis
Meixi Peng, Dan Yang, Yixuan Hou, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 3
Open Access | Times Cited: 81
Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches
Saikat Ghosh, Ankit Javia, Saritha Shetty, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 27-58
Closed Access | Times Cited: 66
Molecular Targets of Triple-Negative Breast Cancer: Where Do We Stand?
Emma E. Newton, Lauren Mueller, Scout Treadwell, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 482-482
Open Access | Times Cited: 41
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition
Ewa Błaszczak, Paulina Miziak, Adrian Odrzywolski, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 228-228
Open Access | Times Cited: 1
Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment
Santhosh Kalash Rajendrakumar, Saji Uthaman, Chong-Su Cho, et al.
Biomacromolecules (2018) Vol. 19, Iss. 6, pp. 1869-1887
Closed Access | Times Cited: 71
Positive feedback loop between mitochondrial fission and Notch signaling promotes survivin-mediated survival of TNBC cells
Li Chen, Jing Zhang, Zhuomin Lyu, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 11
Open Access | Times Cited: 65
Tetrandrine-Induced Autophagy in MDA-MB-231 Triple-Negative Breast Cancer Cell through the Inhibition of PI3K/AKT/mTOR Signaling
Yubo Guo, Xiaohua Pei
Evidence-based Complementary and Alternative Medicine (2019) Vol. 2019, pp. 1-11
Open Access | Times Cited: 64
Activated Platelets‐Targeting Micelles with Controlled Drug Release for Effective Treatment of Primary and Metastatic Triple Negative Breast Cancer
Yujie Zhang, Xi Zhu, Han Y. H. Chen, et al.
Advanced Functional Materials (2019) Vol. 29, Iss. 13
Closed Access | Times Cited: 62
Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
Connie Kang, Yahiya Y. Syed
Drugs (2020) Vol. 80, Iss. 6, pp. 601-607
Closed Access | Times Cited: 58
Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway
Bo Peng, Rong He, Qihua Xu, et al.
Pharmacological Research (2019) Vol. 142, pp. 1-13
Closed Access | Times Cited: 57
Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review
Amir Tajbakhsh, Mahdi Rivandi, Soheila Abedini, et al.
Critical Reviews in Oncology/Hematology (2019) Vol. 140, pp. 17-27
Closed Access | Times Cited: 57
LncRNA HEIH/miR‐939‐5p interplay modulates triple‐negative breast cancer progression through NOS2‐induced nitric oxide production
Heba Nafea, R.A. Youness, Khaled Abou‐Aisha, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 7, pp. 5362-5372
Closed Access | Times Cited: 51
BMP4 enhances anoikis resistance and chemoresistance of breast cancer cells through canonical BMP signaling
Renu Sharma, Gayatri Gogoi, Snigdha Saikia, et al.
Journal of Cell Communication and Signaling (2021) Vol. 16, Iss. 2, pp. 191-205
Open Access | Times Cited: 42
Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 542-542
Open Access | Times Cited: 32
Mapping Intellectual Structures and Research Hotspots of Triple Negative Breast Cancer: A Bibliometric Analysis
Kai-jun Hao, Xiao Jia, Wenting Dai, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 31
New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis
Ana F. Castillo, Ulises Orlando, Paula Maloberti, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 6, pp. 2893-2910
Open Access | Times Cited: 49
An in vitro hyaluronic acid hydrogel based platform to model dormancy in brain metastatic breast cancer cells
Akshay A. Narkhede, James H. Crenshaw, David K. Crossman, et al.
Acta Biomaterialia (2020) Vol. 107, pp. 65-77
Closed Access | Times Cited: 48
Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer
Milica Nedeljković, Nasta Tanić, Mirjana Prvanović, et al.
Breast Cancer (2021) Vol. 28, Iss. 3, pp. 727-736
Closed Access | Times Cited: 40
Extraction of chlorophyll and carotenoids loaded into chitosan as potential targeted therapy and bio imaging agents for breast carcinoma
Nemany A.N. Hanafy, Stefano Leporatti, Maged El‐Kemary
International Journal of Biological Macromolecules (2021) Vol. 182, pp. 1150-1160
Closed Access | Times Cited: 37
Page 1 - Next Page

Scroll to top